
- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index

Symptoms, diagnosis and treatment of chemical burns
ceration, vascularization, symblepharon), and less often of the inner eye (retinitis) have been described.
Phenol
Phenol, also known as carbolic acid, hydroxybenzene or phenylic acid is a toxic, white crystalline solid with the chemical formula C6H5OH. Its structure is that of a hydroxyl group (-OH) bonded to a phenyl ring, making it an aromatic compound. The boiling and melting points are 182 and 41 °C respectively [21]. Nowadays it is used in the manufacture of plastics, explosives, fertilizers, paint or textiles [24], but its disinfectant properties were investigated and used already 1867 by Lister in aseptic surgery. Since that time, phenol is used widely in medical and pharmaceutical properties.
Phenol is corrosive to human skin, but due to its local anesthetic properties, extensive damage may occur before pain is recognized. Dependent on its concentration, dermal contact with phenolic compunds result in irritation, dermatitis, abnormal pigmentation and burns. Up to secondor third degree burns may be caused by the concentrated phenol because of its caustic and defatting (hydrophobic effect of phenol) properties [21]. Prolonged contact elicits denaturation, necrosis and gangrene. However, systemic toxicity and poisoning usually occur by skin absorption with a possibly lethal result. It is reported that the application of a 1% lotion for 7–17 days will result in seizures and coma [33]. Chemical burns from skin exposures with phenol must be decontaminated by washing with polyethylene glycol 300 or 400 [5] isopropyl alcohol [13] or water [28]. Removal of contaminated clothing is required, as well as immediate hospital treatment for large splashes. This is particularly important if the phenol is mixed with chloroform (commonly used mixture in molecular biology for DNA & RNA purification from proteins). It is essential to obtain blood count, electrolytes, urinanalysis and baseline renal and liver measurements after phenol exposure. The acid-base balance of blood should be monitored closely. The normal blood concentration of total phenol is 0.15–7.96 mg/100 mL. The normal range of phenol in urine is 0.5–81.5 mg/L. The highest level of phenol is detected in urine 8–10h after initial exposure [21].
In case of pulmonary exposure, tachypnea, stridor, pulmonary edema and bronchospasm may occur. However, phenol is not considered a serious respiratory hazard in the workplace because of its low volatility [21]. In case of inhalation a cardio-vas- cular monitoring and administration of symptomatic treatment is necessary. Endotracheal intubation and assisted ventilation should be provided as required, as phenol-induced pulmonary trauma being consistent with adult respiratory distress syndrome.
Phenol and its vapor are irritating and corrosive to the eyes with resulting tearing, conjunctivitis and corneal/conjunctival edema. Severe corneal injury may result in white and hypesthetic corneas or corneal necrosis [29]. Again, irrigation of the eyes with copious amounts of water or 0.9% saline solution, local anesthesia application and ophthalmologic examination should be performed.
The substance can cause harmful effects on the central nervous system and heart, such as dysrhythmia, seizures, and coma [33]. In cases of long-term or repeated exposure of phenol effects on the liver and kidneys are reported [34]. Exposure may result in death and the effects can be delayed. The substance is a suspected carcinogen. Besides its hydrophobic effects, another mechanism for the toxicity of phenol may be the formation of phenoxyl radicals [10].
Summary
Chemical burn traumata usually occur in chemical industry, during transportation and handling of hazardous materials or at home. The acids or bases cause protein denaturation in tissues, resulting in cell damage and apoptosis with subsequent necrosis. The extent of damage depends on the type, amount, and concentration of the caustic substances, but also on the duration of exposure. Disrupting the pathophysiological mechanism of the chemical reaction at an early stage is therefore the foremost goal of any medical treatment. In the skin, acids causes coagulation necroses that in most cases keep the acids from penetrating into deeper-lying tissue. Bases cause colliquative necroses that permit diffusion and penetration into underlying tissues with a subsequent more extensive corrosive effect. Firstto
459

L. Kolios, G. Germann
third-degree burns with their respective subsequent scarring result and treatment can occur according to thermal burns. All other possibly affected organ systems must be examined. Pulmonary emergency diagnostics and therapy are preeminent: monitoring of peripheral oxygenation, thoracic x-rays, oxygen donation and periodical steroid application. Inoculation traumata are to be rinsed out extensively, decontaminated with diphoterines / chelates and treated with panthenol-containing gel after ophthalmologic consultation. In the case of oral ingestion regurgitation is contraindicated to avoid another contact of the acid with the oesophageal mucosa. Application of any liquid for dilution and of proton pump inhibitors to prevent inflammation and strictures is necessary as well as a gastroduodenoscopy. To reduct Met-Hb in case of a methemoglobinaemia application of toluidin-blue, methylen-blue, thionine or ascorbic acid is recommended. A renal affection requires forced diuresis, if necessary supported by mannitol and bicarbonate.
References
[1]Abdülkadir G, Oktay M (2002) Esophageal motility changes in acute and late periods of caustic esophageal burns and their relation to prognosis in children. J Pediatr Surg 37: 1526–1528
[2]Alan H, Hall MD (2002) Diphoterine zur Notfallbehandlung zur Dekontamination von chemischen Augen/Hautspritzern: Ein Überblick. Vet Human Toxicol 44 (4)
[3]Anderson KD, Rouse TM, Randolph JG (1990) A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med 323: 637–640
[4]BASF Medical Guidelines for Acute Exposure of Chemical Substances, R1. State 2006. Codes D015–001, D018–002, D026–002, D023–001
[5]Brown VKH, Box VL, Simpson BJ (1975) Decontamination procedures for skin exposed to phenolic substances. Arch Environ Health 30: 1–6
[6]Canadian Centre for Occupational Health and Safety (CCOHS). Nitric acid, Cheminfo 2007
[7]Desel H, Neurath H, Behrens A (2004) Toxikologische Labordiagnostik und Bedside-Tests bei Vergiftungen. Monatsschrift Kinderheilkd 152: 1062–1068
[8]Gabilondo Zubizarreta FJ, Melendez Baltanas J (1999) The management of chemical burns. Eur J Plast Surg 22: 157–161
[10]Hanscha Corwin, McKarnsb Susan C, Smith Carr J, Doolittle David J (2000) Comparative QSAR evidence for a free-radical mechanism of phenol-induced toxicity. Chemico-Biological Interactions 127: 61–72
[11]Health and Safety Executive (HSE) (2005) EH40/2005 Workplace Exposure Limits
[12]Hoppe U, Klose R (2005) Das Inhalationstrauma bei Verbrennungspatienten: Diagnostik und Therapie. Intensivmed 42: 425–439
[13]Hunter DM, Timerding BL, Leonard RB, McCalmont TH, Schwartz E (1992) Effects of isopropyl alcohol, ethanol, and polyethylene glycol/industrial methylated spirits in the treatment of acute phenol burns. Ann Emerg Med 21: 1303–1307
[14]International Agency for Research in Cancer (2010) IARC Monographs on the evaluation of Carcinogenic Risks to Humans. http://monographs. iarc. fr
[15]Kafka G, Maybauer DM, Traber DL, Maybauer MO (2007) Das Rauchgasinhalationstrauma in der präklinischen Versorgung. Notfall Rettungsmed 10: 529–540
[16]Karow T (2002) Allgemeine und Spezielle Pharmakologie und Toxikologie, 10th edn. Karow, Pulheim
[17]Katzka DA (2001) Caustic injury to the esophagus. Curr Treat Options Gastroenterol 4: 59–66
[18]Kolios L, Striepling E, Kolios G, Rudolf KD, Dresing K, Dörges J, Stürmer KM, Stürmer EK (2009) The Nitric acid burn trauma of the skin. J Plast Reconstr Aesthet Surg [Epub ahead of print]
[19]Kurzai M, Köhler H (2005) Gastrointestinale Verätzung und Fremdkörperingestion. Monatsschrift Kinderheilkd 153: 1197–1208
[20]Langefeld S, Press UP, Frentz M, Kompa S, Schrage N (2003) Verätzungen des Auges, Diphoterinhaltige Augenspüllösung in der Erste-Hilfe-Therapie. Ophthalmologe 100: 727–731
[21]Lin TM, Lee SS, Lai CS, Lin SD (2006) Phenol burn. Burns 32: 517–521
[22]Mamede RCM, De Mello Filho FV (2002) Treatment of caustic ingestion: an analysis of 239 cases. Dis Esophagus 15: 210–213
[23]Monafa WW, Bessey PQ (1997) Wound care. In:Herndon DN (ed) Total burn care. WB Saunders, pp 88–97
[24]Monteiro-Riviere NA, Inman AO, Jackson H, Dunn B, Dimond S (2001) Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin. Toxicol Ind Health 17: 95–104
[25]Mutschler E, Geisslinger G (2008) Lehrbuch der Pharmakologie und Toxikologie, Arzneimittelwirkungen, 9. Aufl., Wissensch. Verlagsgesellschaft mbH, Stuttgart
[26]Pallua N, Noah EM, Radke K (2000) Inhalationstrauma bei Verbrennungen. Intensivmed 37: 284–292
[9]GESTIS-database on hazardous substances (2010) [27] Pallua N, von Bülow S (2006) Behandlungskonzepte
www.dguv.de/ifa/gestis-database |
bei Verbrennungen. Der Chirurg 77: 179–192 |
460

Symptoms, diagnosis and treatment of chemical burns
[28]Pullin TG, Pinkerton MN, Johnson RV, Kilian DJ (1978) Decontamination of the skin of swine following phenol exposure: a comparison of the relative efficacy of water versus polyethylene glycol/industrial methylated spirits. Toxicol Appl Pharmacol 43: 199–206
[29]Saydjari R, Abston S, Desai MH, Herndon DN (1986) Chemical burns. J Burn Care Rehabil 7: 404–408
[30]Topaloglu B, Bicakci U, Tander B (2008) Biochemical and histopathologic effects of omeprazol and vitamin E in rats with corrosive esophageal burns. Pediatr Surg Int 24: 555–560
[31]Toxin Information Centre of Rheinland-Pfalz and Hessen (2008) Clinical toxicology of the II. Medical Clinic. Johannes-Gutenberg University Mainz
[32]Vogt PM, Kolokythas P (2007) Innovative Wundtherapie und Hautersatz bei Verbrennungen. Chirurg 78: 335–342
[33]Warner MA, Harper JV (1985) Cardiac dysrhythmias associated with chemical peeling with phenol. Anesthesiology 62: 366–367
[34]World Health Organization/International Labour Organization: International Chemical Safety Cards, http://www.ilo.org/public/english/protection/safework/cis/products/icsc/dtasht/_icsc00/icsc0070.htm
[35]Zargar SA, Kochhar, Metha S (1991) The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointest Endosc 37: 165–167
Correspondence: Leila Kolios, M.D., Clinic for Hand-, Plastic & Reconstructive Surgery – Burn Center – Clinic for Plastic & Hand Surgery at Heidelberg University Hospital, BG Trauma Center Ludwigshafen, Ludwig-Guttmann-Straße 13, 67071 Ludwigshafen, Germany, E-mail: lkolios@bgu-ludwigshafen.de
461